Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SERPINA3 Monoclonal Antibody (1AC10-128.1), Invitrogen™
Mouse Monoclonal Antibody
Supplier: Thermo Scientific MA110631
Description
MA1-10631 detects alpha-1 Antichymotrypsin from human samples. MA1-10631 has been successfully used in ELISA applications. The MA1-10631 immunogen is purified human serum alpha-1 Antichymotrypsin.
SERPINA encodes Alpha 1-ACT. It is an early-stage acute-phase plasma protein and a serpin that preferentially inactivates chymotrypsin, cathepsin G, and chymase. Alpha-1-ACT, a serine protease inhibitor, is tightly associated with amyloid plaques in Alzheimer's disease (AD) and in normal aged human and monkey brain. Regulation of the serine proteases and serine protease inhibitors plays an important role in neuromuscular differentiation. Prostate specific antigen (PSA), a chymotrypsin-like serine protease, is predominantly complexed to Alpha-1-ACT.
Specifications
SERPINA3 | |
Monoclonal | |
1 mg/mL | |
PBS with no preservative; pH 7.4 | |
P01011 | |
SERPINA3 | |
Purified human serum alpha-1 Antichymotrypsin. | |
500 μg | |
Primary | |
Human | |
Antibody | |
IgG1 |
ELISA | |
1AC10-128.1 | |
Unconjugated | |
SERPINA3 | |
AACT; ACT; alpha-1-antichymotrypsin; Alpha-1-antichymotrypsin His-Pro-less; Cell growth-inhibiting gene 24/25 protein; GIG24; GIG25; Growth inhibiting protein 24; Growth inhibiting protein 25; growth-inhibiting protein 24; growth-inhibiting protein 25; MGC88254; Serine (or cysteine) proteinase inhibitor clade A member 3; serine (or cysteine) proteinase inhibitor, clade A, member 3; serpin A3; serpin family A member 3; Serpin peptidase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 3; serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3; SERPINA3 | |
Mouse | |
Protein G | |
RUO | |
12 | |
-20° C, Avoid Freeze/Thaw Cycles | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction